Amgen is one of the world’s leading biotechnology companies. This company is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses. They offers products for the treatment of illness in the areas of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience.

Research Grants 62 show all


$50.7M
2015

$10.6M
2016

$25.1M
2017

$7.5M
2018

$43.7M
2019

Patents 21,136show all

  • 3,824
    A61K - Preparations for medical, dental, or toilet purposes
  • 3,625
    C07K - Peptides
  • 2,103
    C07D - Heterocyclic compounds
  • 1,483
    G06F - Electric digital data processing
  • 1,134
    C12N - Microorganisms or enzymes
  • 868
    G11C - Static stores
  • 713
    H01L - Semiconductor devices
  • 688
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 581
    H03K - Pulse technique
  • 414
    A01K - Animal husbandry

Clinical Trials 2,898show all

882Phase 3827N/A573Phase 2248Phase 1244Other

SEC Filings show all


240
8-K

79
10-Q

24
10-K

2
D

Contact Information

One Amgen Center Drive
Thousand Oaks, CA 91320
United States

Overview

Total FundingEmployeesLast Funding DateStatus
10000+Ipo

SEC Form D Funding Events

DateOfferedSoldType
2015-01-23$2,500,000,000$0Other
2008-05-23Unknown Unknown Other (Paper Filing)

Key Executives

  • Robert A. Bradway
    Executive Officer, Director
  • Madhavan Balachandran
    Executive Officer
  • Sean E. Harper
    Executive Officer
  • Anthony C. Hooper
    Executive Officer
  • Brian M. McNamee
    Executive Officer
  • David J. Scott
    Executive Officer
  • David Baltimore
    Director
  • Frank J. Biondi, Jr.
    Director
  • Francois de Carbonnel
    Director
  • Vance D. Coffman
    Director
  • Robert A. Eckert
    Director
  • Greg C. Garland
    Director
  • Rebecca M. Henderson
    Director
  • Frank C. Herringer
    Director
  • Tyler Jacks
    Director
  • Judith C. Pelham
    Director
  • Ronald D. Sugar
    Director
  • David W. Meline
    Executive Officer
  • Cynthia M. Patton
    Executive Officer
  • David Piacquad
    Executive Officer
  • Stuart A. Tross
    Executive Officer
  • R. Sanders Williams
    Director